BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2414192)

  • 1. Aggristin (ristomycin) precipitation test: a new tool for the detection of fibrin monomer and fibrin degradation products.
    Pfliegler G; Vogel G; Boda Z; Zajka G; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):629-35. PubMed ID: 2414192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ristocetin precipitation test: a new simple test for detection of fibrin monomer and fibrin degradation products.
    Watanabe K; Tullis JL
    Am J Clin Pathol; 1978 Oct; 70(4):691-6. PubMed ID: 707435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
    Niewiarowski S; Gurewich V
    J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for measurement of fibrin monomer with the use of an immune precipitate of fibrinogen.
    Kisker CT; Plummer G; Taylor B; Rush R
    J Lab Clin Med; 1977 Mar; 89(3):653-8. PubMed ID: 839123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
    Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
    Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation products of fibrinogen and crosslinked fibrin-projected clinical applications.
    Marder VJ; Budzynski AZ
    Thromb Diath Haemorrh; 1974 Sep; 32(1):49-56. PubMed ID: 4616425
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of the enzyme preparation ancistron-N in the diagnosis of disseminated intravascular coagulation].
    Neĭko EM; Serediuk NN; Fabrika AV
    Vrach Delo; 1990 Apr; (4):57-60. PubMed ID: 2275170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FFDP (fibrin fibrinogen degradation products), D-dimers, and SFMC (soluble fibrin monomer complex)].
    Kuroso K
    Rinsho Byori; 1987 Apr; Spec No 70():224-32. PubMed ID: 3302392
    [No Abstract]   [Full Text] [Related]  

  • 13. [The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].
    Soria J; Soria C; de Rodriguez S; Horellou MH; Samama M; Bilski-Pasquier G
    Nouv Presse Med; 1977 Dec; 6(43):4045-8. PubMed ID: 600751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of partial thromboplastin time and thrombin time in the diagnosis of disseminated intravascular coagulation].
    Frick U; Frick G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):879-81. PubMed ID: 75159
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
    Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
    Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of intravascular coagulation.
    Kisker CT; Rush R
    J Clin Invest; 1971 Nov; 50(11):2235-41. PubMed ID: 5096509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of the staphylococcal clumping test in the diagnosis of disseminated intravascular coagulation in the infected infant].
    Ortiz Méndez VM; Martínez Cabrera S; Olvera Hidalgo C; León Roiz J
    Bol Med Hosp Infant Mex; 1981; 38(4):585-94. PubMed ID: 7295369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.